Brokerages Recommend Bajaj Finserv, Sun Pharma and Others for 2026 Investment
Brokerages recommend several stocks for long-term investment in 2026, highlighting potential returns between 10% and 35%. Motilal Oswal upgraded Bajaj Finserv to a Buy rating with a target price of Rs 2,490 after the company reported a 12% rise in Q1 net profit to Rs 3,132 crore and 19% revenue growth. Other recommended stocks include Sun Pharma, APL Apollo Tubes, Leela Palaces Hotels Resorts, and Chambal Fertilisers Chemicals, with brokerages citing strong sectoral performance despite market volatility.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (72/100). Lens Score 36/100.
Outlets measured: economictimes, economictimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (70–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
economictimes broke this story on 3 Aug, 04:02 am. Other outlets followed.